Vemurafenib for BRAF
Publication/Presentation Date
11-1-2016
Volume
17
Issue
11
First Page
469
Last Page
469
ISSN
1474-5488
Published In/Presented At
Brose, M. S., & Singh, N. (2016). Vemurafenib for BRAFV600E-positive metastatic papillary thyroid cancer - Authors' response. The Lancet. Oncology, 17(11), e469. https://doi.org/10.1016/S1470-2045(16)30520-4
Disciplines
Medicine and Health Sciences
PubMedID
27819236
Department(s)
Hematology-Medical Oncology Division
Document Type
Article
COinS